Bevacizumab's Role in Late-Stage Cervical Cancer

Dr. Maurie Markman discusses the recent FDA approval of bevacizumab for recurrent or late-stage cervical cancer and weighs the benefits of the drug in this setting against its toxicity profile.
Source: Medscape Oncology - Category: Cancer & Oncology Authors: Source Type: podcasts